| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da2f79017444789d747982d4ab13b908 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-47 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6851 |
| filingDate |
2022-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26af11eca85e03126d183b2868ae6d3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_712096d8c053233f109e6e031eb981a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d28b0d61971f55b35620ace9d65f86cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3809242cca310c9baffeb402bf325d13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c274a4efd6832ee042223914fe3e9cf5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f427e0ba8f05d2ddf577646d52eefc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2ef27b65386854048ce1b7aaaa5ca8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46f1b20408c74a5d4f03eab7f5f7d047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_515c5f923c9f82ee79552e6a19623336 |
| publicationDate |
2022-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-114854834-A |
| titleOfInvention |
Application of WDHD1 gene in the prediction of metastasis and recurrence of liver cancer |
| abstract |
The invention discloses the application of WDHD1 gene in the prediction of metastasis and recurrence of liver cancer, and uses WDHD1 as a tumor gene to predict the metastasis and recurrence of liver cancer. The expressed genes were analyzed by combining the results of liver cancer tissue microarray and the data in the TCGA database, and it was found that the expression of WDHD1 was up-regulated in liver cancer tissue. The related tissue sample verification experiments, molecular biology and cell biology experiments were used to verify WDHD1 and liver cancer metastasis and recurrence. It is closely related and can be used as a biomarker for the assessment and prediction of liver cancer metastasis and recurrence. |
| priorityDate |
2022-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |